Bhagat Sujit*
In pharmaceutical technology, the controlled release of drugs remains a cornerstone for improving therapeutic efficacy and patient compliance. Traditional dosage forms often fail to maintain effective plasma concentrations due to rapid transit through the gastrointestinal tract (GIT) and variable gastric emptying times. These limitations have prompted the exploration of novel systems capable of retaining the dosage form at the absorption site for a prolonged period. One such promising approach is the floating microsphere or microballoon system, which provides an effective means of controlled drug delivery via buoyancy mechanisms. Microspheres are typically defined as free-flowing spherical particles with diameters ranging between 1 and 1000 μm (Janjale et al., 2020). They can be composed of natural polymers (e.g., sodium alginate, gelatin, chitosan), synthetic polymers (e.g., Eudragit, polymethyl methacrylate, polylactic acid), or their blends. The floating property of these microspheres is imparted by entrapping air or gas within the matrix or by incorporating effervescent agents that generate CO? when exposed to acidic conditions. This results in a bulk density lower than that of gastric fluid, ensuring the microspheres remain buoyant for extended periods. The floating microsphere system has distinct advantages over conventional single-unit floating tablets. Whereas single-unit systems are subject to unpredictable gastric emptying (the “all-or-none” phenomenon), multi-particulate microspheres distribute uniformly throughout the stomach and small intestine, leading to consistent and reproducible drug release. This feature significantly reduces localized irritation and variability in bioavailability (Ma et al., 2008).
Floating microspheres are particularly beneficial for drugs with:
Narrow absorption windows in the upper GIT (e.g., levodopa, riboflavin).
Instability or poor solubility in alkaline pH (e.g., verapamil, amoxicillin).
Short biological half-life requiring sustained release (e.g., diltiazem hydrochloride).
Local action in the stomach (e.g., antacids, antibiotics for H. pylori eradication).
Over the past decade, researchers have developed microsphere formulations for a wide variety of therapeutic agents. For instance, Eudragit RS100-based microballoons of metformin provided sustained release up to 12 hours (Singh et al., 2022), while alginate–chitosan systems demonstrated enhanced encapsulation efficiency for hydrophilic drugs (Li et al., 2018). Furthermore, hybrid microspheres have been explored for co-delivery of drugs with different solubility profiles, paving the way for fixed-dose combination therapies. Beyond oral delivery, floating microsphere concepts have been extended to pulmonary aerosols (where buoyant microparticles enhance residence time in alveoli) and topical formulations (providing controlled release in dermal layers). These developments demonstrate the flexibility of floating microsphere systems as multifunctional drug delivery platforms. In summary, floating microspheres address the central challenge of maintaining a controlled residence time and predictable drug release profile in diverse biological environments. Their design integrates principles of polymer chemistry, physical pharmaceutics, and biopharmaceutics, offering a bridge between formulation science and therapeutic optimization.
MECHANISM OF FLOATATION
The buoyancy mechanism of floating microspheres is a delicate interplay between formulation density, polymer swelling, and gas entrapment. When introduced into the gastrointestinal fluid, the polymer matrix absorbs water and swells, forming a gel barrier that traps air or generated gas within the microsphere core. This entrapment lowers the overall density below that of gastric fluid (≈1.004 g/cm³), allowing the system to remain afloat. The floatation force (F) acting on a microsphere is derived from Archimedes’ principle:
F = (ρ_f - ρ_s) V g
where ρ_f represents the density of gastric fluid, ρ_s the density of the microsphere, V the volume of displaced fluid, and g the gravitational acceleration. A positive buoyant force keeps the microsphere afloat at the liquid surface, while a negative force causes sinking.
Two fundamental mechanisms support floatation:
2.1 Effervescent Mechanism
In this system, gas-generating agents such as sodium bicarbonate, citric acid, or tartaric acid are incorporated. Upon exposure to acidic gastric fluid, CO? is liberated and entrapped within the hydrated polymer matrix, creating internal pores and decreasing density. The generated CO? bubbles become locked within the gel barrier, sustaining buoyancy for 8–12 hours. For example, Ma et al. (2008) formulated calcium alginate–chitosan microspheres where CO? entrapment enabled floating for over 10 hours without compromising release kinetics.
2.2 Non-Effervescent Mechanism
Non-effervescent microspheres rely solely on the inherent low density and swelling of the polymers used. Polymers such as ethyl cellulose, Eudragit RS, HPMC, and PLA form a matrix that retains air pockets during solidification or solvent evaporation. These air-filled voids maintain buoyancy even without gas-forming additives. Non-effervescent systems often demonstrate superior mechanical stability and more predictable release profiles due to the absence of internal gas evolution.
2.3 Role of Polymer Hydration and Cross-Linking
Hydrophilic polymers swell upon hydration, forming a gel network that not only controls drug diffusion but also modulates buoyancy. Cross-linking agents (e.g., calcium chloride, glutaraldehyde) stabilize this gel network, reducing water penetration and prolonging floating duration. Excessive cross-linking, however, can hinder swelling and reduce floating capacity, requiring optimization through experimental design.
2.4 Influence of Surface Topography
Surface porosity also dictates floatation. Microspheres with rugged or porous surfaces trap more air during formation, enhancing buoyancy, while smooth, compact microspheres tend to sink faster. Scanning electron microscopy (SEM) often reveals the structural differences correlating with floating ability.
10.5281/zenodo.17638545